Enefexine (INN), also known as 4-(4-ethylphenyl)piperidine, is a drug of the phenylpiperidine group which is described as an antidepressant but was never marketed.[1][2] It was first described in the literature by 1983.[1][3] The drug was developed by Ciba-Geigy.[3]
 | |
| Clinical data | |
|---|---|
| Other names | 4-(4-Ethylphenyl)piperidine |
| Drug class | Antidepressant |
| Identifiers | |
| |
| CAS Number |
|
| PubChem CID | |
| ChemSpider | |
| UNII | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C13H19N |
| Molar mass | 189.302 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
See also
editReferences
edit- ^ a b Elks J (2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer US. p. 519. ISBN 978-1-4757-2085-3. Retrieved 20 October 2024.
- ^ Use of stems in the selection of International Nonproprietary Names (INN) for pharmaceutical substances (PDF). World Health Organization. 2024. p. 100. ISBN 978-92-4-009938-8.
- ^ a b CH 634298, Georges H, Alberto R, Giorgio FP, Oswald S, "Process for preparing phenylazacycloalkanes", published 31 January 1983, assigned to Ciba Geigy AG
 | This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it. |